Source:http://linkedlifedata.com/resource/pubmed/id/16307918
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-11-25
|
pubmed:abstractText |
The phosphoinositide 3-kinase (PI 3-K) signaling axis is intimately associated with deregulated cancer cell growth, primarily by promoting increased survival through Akt/PKB (protein kinase B). However, there is relatively little information on the role of Akt in cancer cell motility, a key phenotype of invasive carcinomas. Here we report that activation of Akt inhibits carcinoma migration and invasion of breast cancer cells. Conversely, downregulation of Akt using RNA interference increased migration and invasion. Akt blunts invasion by inhibiting the transcriptional activity of NFAT (nuclear factor of activated T cells). Specifically, signaling through Akt reduces NFAT expression levels due to ubiquitination and proteasomal degradation, mediated by the E3 ubiquitin ligase HDM2. These results indicate that while Akt can promote tumor progression through increased cell survival mechanisms, it can block breast cancer cell motility and invasion by a mechanism that depends, at least in part, on the NFAT transcription factor.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/NFATC Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-mdm2,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1097-2765
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
539-50
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16307918-Animals,
pubmed-meshheading:16307918-Breast Neoplasms,
pubmed-meshheading:16307918-Cell Line, Tumor,
pubmed-meshheading:16307918-Cell Migration Inhibition,
pubmed-meshheading:16307918-Cell Movement,
pubmed-meshheading:16307918-Female,
pubmed-meshheading:16307918-Humans,
pubmed-meshheading:16307918-Mice,
pubmed-meshheading:16307918-NFATC Transcription Factors,
pubmed-meshheading:16307918-NIH 3T3 Cells,
pubmed-meshheading:16307918-Neoplasm Invasiveness,
pubmed-meshheading:16307918-Proteasome Endopeptidase Complex,
pubmed-meshheading:16307918-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:16307918-Proto-Oncogene Proteins c-mdm2,
pubmed-meshheading:16307918-Ubiquitin
|
pubmed:year |
2005
|
pubmed:articleTitle |
Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT.
|
pubmed:affiliation |
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|